MEDIFAST INC EBITDA Margin 2010-2024 | MED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for MEDIFAST INC (MED) over the last 10 years. The current EBITDA margin for MEDIFAST INC as of June 30, 2024 is .
MEDIFAST INC EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-06-30 |
$0.77B |
$0.05B |
6.10% |
2024-03-31 |
$0.90B |
$0.09B |
10.47% |
2023-12-31 |
$1.07B |
$0.14B |
12.97% |
2023-09-30 |
$1.22B |
$0.16B |
13.38% |
2023-06-30 |
$1.37B |
$0.19B |
13.48% |
2023-03-31 |
$1.53B |
$0.20B |
12.75% |
2022-12-31 |
$1.60B |
$0.20B |
12.33% |
2022-09-30 |
$1.64B |
$0.21B |
12.87% |
2022-06-30 |
$1.66B |
$0.22B |
13.06% |
2022-03-31 |
$1.60B |
$0.23B |
14.22% |
2021-12-31 |
$1.53B |
$0.22B |
14.68% |
2021-09-30 |
$1.41B |
$0.21B |
14.93% |
2021-06-30 |
$1.27B |
$0.20B |
15.74% |
2021-03-31 |
$1.10B |
$0.17B |
15.22% |
2020-12-31 |
$0.93B |
$0.14B |
14.78% |
2020-09-30 |
$0.84B |
$0.12B |
14.17% |
2020-06-30 |
$0.76B |
$0.10B |
12.52% |
2020-03-31 |
$0.73B |
$0.09B |
12.95% |
2019-12-31 |
$0.71B |
$0.10B |
13.31% |
2019-09-30 |
$0.69B |
$0.10B |
14.22% |
2019-06-30 |
$0.64B |
$0.09B |
14.73% |
2019-03-31 |
$0.57B |
$0.08B |
14.61% |
2018-12-31 |
$0.50B |
$0.07B |
14.57% |
2018-09-30 |
$0.43B |
$0.06B |
14.55% |
2018-06-30 |
$0.37B |
$0.06B |
15.09% |
2018-03-31 |
$0.33B |
$0.05B |
15.45% |
2017-12-31 |
$0.30B |
$0.05B |
14.90% |
2017-09-30 |
$0.29B |
$0.04B |
14.69% |
2017-06-30 |
$0.28B |
$0.04B |
14.75% |
2017-03-31 |
$0.27B |
$0.03B |
12.45% |
2016-12-31 |
$0.27B |
$0.03B |
11.68% |
2016-09-30 |
$0.27B |
$0.03B |
11.36% |
2016-06-30 |
$0.27B |
$0.03B |
11.48% |
2016-03-31 |
$0.27B |
$0.04B |
12.92% |
2015-12-31 |
$0.27B |
$0.04B |
12.87% |
2015-09-30 |
$0.27B |
$0.03B |
12.45% |
2015-06-30 |
$0.28B |
$0.03B |
11.59% |
2015-03-31 |
$0.28B |
$0.03B |
12.19% |
2014-12-31 |
$0.29B |
$0.04B |
13.33% |
2014-09-30 |
$0.27B |
$0.04B |
16.48% |
2014-06-30 |
$0.28B |
$0.05B |
16.20% |
2014-03-31 |
$0.31B |
$0.05B |
15.36% |
2013-12-31 |
$0.32B |
$0.05B |
14.24% |
2013-09-30 |
$0.32B |
$0.04B |
12.96% |
2013-06-30 |
$0.33B |
$0.04B |
13.37% |
2013-03-31 |
$0.33B |
$0.04B |
11.66% |
2012-12-31 |
$0.32B |
$0.04B |
11.29% |
2012-09-30 |
$0.34B |
$0.03B |
9.30% |
2012-06-30 |
$0.33B |
$0.03B |
8.81% |
2012-03-31 |
$0.31B |
$0.03B |
10.54% |
2011-12-31 |
$0.30B |
$0.04B |
12.08% |
2011-09-30 |
$0.29B |
$0.04B |
13.40% |
2011-06-30 |
$0.28B |
$0.04B |
14.54% |
2011-03-31 |
$0.27B |
$0.04B |
15.13% |
2010-12-31 |
$0.26B |
$0.04B |
15.12% |
2010-09-30 |
$0.24B |
$0.04B |
15.70% |
2010-06-30 |
$0.22B |
$0.03B |
15.38% |
2010-03-31 |
$0.20B |
$0.03B |
14.80% |
2009-12-31 |
$0.17B |
$0.02B |
14.12% |
Sector |
Industry |
Market Cap |
Revenue |
Consumer Staples |
Food Items - Miscellaneous/Diversified |
$0.201B |
$1.072B |
Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company boasts a diversified portfolio of consumable product options, which include bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes and soups. The company sells different types of products, which are formed on the basis of its proprietary formulas across the United States and the Asia-Pacific. The products are sold under brands such as the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life and Flavors of Home. OPTAVIA product line is sold through its community of independent coaches who offer support and guidance to their clients.
|